WARNINGMIXING OR WITHDRAWAL CAN BE DANGEROUS
Ordinary doses in combination with other depressants can fatally stop breathing. After prolonged dependency, stopping suddenly can also cause seizures or delirium; seek medical help.
Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
Flurazepam
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Pharmacology
Dangerous
Highest riskThese combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
Unsafe
AvoidThere is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
Caution
Use cautionThese combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Tolerance
Harm Potential
Addiction & Dependence
Psychological
HighFlurazepam has significant abuse potential with risk of psychological dependence. Recreational misuse occurs where the drug is taken to achieve a high, and continued use against medical advice is common. The FDA required a boxed warning describing risks of abuse, misuse, and addiction for all benzodiazepines.
Physical
HighLong-term use is associated with drug tolerance and physical dependence. After discontinuation, a rebound effect or benzodiazepine withdrawal syndrome may occur approximately four days after stopping medication. Flurazepam shares cross tolerance with barbiturates, indicating significant physical dependence potential.
Toxicity
Flurazepam combined with alcohol or other CNS depressants may produce fatal results. Overdose symptoms include coma, confusion, low blood pressure, and severe sleepiness.
Chronic use causes cognitive impairment including anterograde amnesia, daytime sedation, and motor incoordination; these effects may persist as residual hangover effects after nighttime administration and impair next-day functioning.
Use is associated with impairments in body balance and standing steadiness, leading to increased risk of falls and hip fractures, particularly in individuals who wake at night or the next morning.
In a meta-analysis, people using hypnotic drugs had 44% more mild infections, including examples such as pharyngitis and sinusitis, than those receiving placebo.
Psychosis Risk
Paradoxical agitation or disinhibition may occur, particularly in elderly patients, though this is considered a moderately higher risk compared to non-benzodiazepine sedatives rather than a common occurrence.
History & Culture
Legality
International
Controlled internationally under the UN Convention on Psychotropic Substances 1971.
References
Source Pages
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Flurazepam article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.